477 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
of 10 | next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
ABCA5 ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5 Expressed in all
ABCB9 ATP-binding cassette, sub-family B (MDR/TAP), member 9
Vesicles Glioma: 4.62e-4 Tissue enhanced testis: 23.9
ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9
Nucleoplasm Cytosol Renal cancer: 1.85e-5 Mixed
ABCD3 ATP-binding cassette, sub-family D (ALD), member 3
Peroxisomes Colorectal cancer: 1.16e-5 Renal cancer: 4.84e-5 Expressed in all
ABCD4 ATP-binding cassette, sub-family D (ALD), member 4
Expressed in all
ACKR1 Atypical chemokine receptor 1 (Duffy blood group)
Cervical cancer: 2.52e-5 Liver cancer: 1.48e-4 Thyroid cancer: 9.76e-4 Mixed
ACKR2 Atypical chemokine receptor 2
Nucleoplasm Vesicles Cytosol Tissue enhanced placenta: 22.8
ACSL3 Acyl-CoA synthetase long-chain family member 3
Nucleoli Lipid droplets Liver cancer: 2.75e-4 Lung cancer: 8.78e-4 Expressed in all
ACSL4 Acyl-CoA synthetase long-chain family member 4
Golgi apparatus Mitochondria Urothelial cancer: 5.73e-4 Expressed in all
ACSL5 Acyl-CoA synthetase long-chain family member 5
Nucleus Mitochondria Endometrial cancer: 1.13e-4 Expressed in all
ACSL6 Acyl-CoA synthetase long-chain family member 6
Group enriched 6 bone marrow: 18.0 cerebral cortex: 62.1 parathyroid gland: 22.1 seminal vesicle: 28.7 testis: 51.2
ADCYAP1R1 Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
Vesicles Endometrial cancer: 5.78e-4 Tissue enhanced cerebral cortex: 137.5 fallopian tube: 46.5
ADGRD1 Adhesion G protein-coupled receptor D1
Nucleus Cytosol Liver cancer: 9.27e-4 Tissue enhanced placenta: 44.3
ADGRL4 Adhesion G protein-coupled receptor L4
Renal cancer: 1.60e-4 Mixed
ADORA1 Adenosine A1 receptor
Plasma membrane Tissue enhanced cerebral cortex: 46.5 testis: 23.4
AGPAT2 1-acylglycerol-3-phosphate O-acyltransferase 2
Centrosome Expressed in all
AGTRAP Angiotensin II receptor-associated protein
Vesicles Liver cancer: 6.57e-7 Expressed in all
AIG1 Androgen-induced 1
Golgi apparatus Head and neck cancer: 3.25e-7 Cervical cancer: 3.26e-6 Endometrial cancer: 3.06e-4 Expressed in all
ALDH3A2 Aldehyde dehydrogenase 3 family, member A2
Renal cancer: 3.85e-8 Expressed in all
ALG12 ALG12, alpha-1,6-mannosyltransferase
Endoplasmic reticulum Renal cancer: 3.60e-5 Endometrial cancer: 6.09e-4 Expressed in all
ALG8 ALG8, alpha-1,3-glucosyltransferase
Nucleoplasm Expressed in all
ALOX5AP Arachidonate 5-lipoxygenase-activating protein
Renal cancer: 5.68e-4 Ovarian cancer: 6.44e-4 Expressed in all
ANO10 Anoctamin 10
Renal cancer: 6.41e-6 Endometrial cancer: 1.11e-4 Liver cancer: 3.19e-4 Colorectal cancer: 6.70e-4 Expressed in all
ANO2 Anoctamin 2, calcium activated chloride channel
Nucleoplasm Plasma membrane Tissue enhanced testis: 17.7
ANO7 Anoctamin 7
Tissue enhanced prostate: 86.9 stomach: 26.2
APH1A APH1A gamma secretase subunit
Expressed in all
APOLD1 Apolipoprotein L domain containing 1
Nucleoplasm Cytosol Tissue enhanced adipose tissue: 142.0
AQP1 Aquaporin 1 (Colton blood group)
Plasma membrane Renal cancer: 1.32e-8 Head and neck cancer: 6.52e-4 Expressed in all
AQP6 Aquaporin 6, kidney specific
Tissue enriched 9 kidney: 20.8
ARL6IP5 ADP-ribosylation factor-like 6 interacting protein 5
Endoplasmic reticulum Expressed in all
ARL6IP6 ADP-ribosylation factor-like 6 interacting protein 6
Nuclear membrane Cytosol Liver cancer: 1.73e-4 Renal cancer: 2.14e-4 Mixed
ARSE Arylsulfatase E (chondrodysplasia punctata 1)
Golgi apparatus Colorectal cancer: 8.95e-4 Tissue enhanced kidney: 41.1 liver: 49.1
ATL2 Atlastin GTPase 2
Endometrial cancer: 4.51e-4 Expressed in all
ATP10A ATPase, class V, type 10A N/A
Renal cancer: 6.60e-5 Mixed
ATP11C ATPase, class VI, type 11C
Mixed
ATP13A2 ATPase type 13A2
Liver cancer: 3.33e-7 Expressed in all
ATP13A3 ATPase type 13A3
Nucleoli Plasma membrane Cytosol Pancreatic cancer: 1.60e-4 Renal cancer: 1.63e-4 Expressed in all
ATP13A4 ATPase type 13A4
Nucleoplasm Head and neck cancer: 3.91e-4 Tissue enhanced epididymis: 89.1 parathyroid gland: 129.5 thyroid gland: 68.2
ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide
Renal cancer: 8.98e-8 Liver cancer: 1.42e-4 Urothelial cancer: 4.01e-4 Expressed in all
ATP2C1 ATPase, Ca++ transporting, type 2C, member 1
Golgi apparatus Liver cancer: 5.06e-6 Pancreatic cancer: 1.52e-4 Renal cancer: 1.55e-4 Expressed in all
ATP6V0A2 ATPase, H+ transporting, lysosomal V0 subunit a2
Plasma membrane Cytosol Expressed in all
ATP6V0B ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b
Cytosol Renal cancer: 3.62e-6 Pancreatic cancer: 3.24e-4 Liver cancer: 4.79e-4 Urothelial cancer: 8.87e-4 Expressed in all
ATP6V0C ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
Cytosol Renal cancer: 1.07e-6 Expressed in all
ATP9B ATPase, class II, type 9B
Expressed in all
BCAP29 B-cell receptor-associated protein 29
Cytosol Liver cancer: 3.62e-4 Expressed in all
BCAP31 B-cell receptor-associated protein 31
Endoplasmic reticulum Head and neck cancer: 9.87e-4 Expressed in all
BEST1 Bestrophin 1
Mixed
BRI3BP BRI3 binding protein
Nucleoplasm Mitochondria Liver cancer: 6.87e-4 Mixed
BSCL2 Berardinelli-Seip congenital lipodystrophy 2 (seipin)
Renal cancer: 7.55e-5 Expressed in all
BVES Blood vessel epicardial substance
Cell Junctions Tissue enhanced smooth muscle: 24.7
Page
of 10 | next »